CONMED CORP's ticker is and the CUSIP is 207410AF8. A total of 34 filers reported holding CONMED CORP in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $627,560 | -82.3% | 541,000 | -77.0% | 0.00% | -100.0% |
| Q2 2023 | $3,554,376 | -25.2% | 2,350,000 | -39.8% | 0.00% | 0.0% |
| Q1 2023 | $4,753,875 | -13.0% | 3,901,000 | -17.5% | 0.00% | -50.0% |
| Q4 2022 | $5,465,288 | -6.0% | 4,726,000 | -10.5% | 0.00% | 0.0% |
| Q3 2022 | $5,816,000 | -36.4% | 5,281,000 | -30.2% | 0.00% | -33.3% |
| Q2 2022 | $9,144,000 | -25.3% | 7,565,000 | +6.2% | 0.00% | 0.0% |
| Q1 2022 | $12,245,000 | -6.7% | 7,121,000 | -9.8% | 0.00% | 0.0% |
| Q4 2021 | $13,124,000 | -56.2% | 7,894,000 | -59.3% | 0.00% | -57.1% |
| Q3 2021 | $29,995,000 | +27.9% | 19,407,000 | +33.3% | 0.01% | +40.0% |
| Q2 2021 | $23,460,000 | +23.5% | 14,560,000 | +19.9% | 0.01% | +25.0% |
| Q1 2021 | $18,989,000 | +82.6% | 12,148,000 | +63.3% | 0.00% | +33.3% |
| Q4 2020 | $10,398,000 | +6522.9% | 7,438,000 | +5212.9% | 0.00% | – |
| Q3 2020 | $157,000 | +6.8% | 140,000 | 0.0% | 0.00% | – |
| Q2 2020 | $147,000 | – | 140,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Mohican Financial Management, LLC | 2,840,000 | $3,958,000 | 4.02% |
| ZAZOVE ASSOCIATES LLC | 13,564,000 | $18,956,000 | 2.33% |
| SHENKMAN CAPITAL MANAGEMENT INC | 10,584,000 | $15,014,000 | 1.57% |
| SSI INVESTMENT MANAGEMENT LLC | 8,349,000 | $11,673,000 | 0.83% |
| OSTERWEIS CAPITAL MANAGEMENT INC | 8,930,000 | $12,528,000 | 0.75% |
| MACKAY SHIELDS LLC | 32,384,000 | $45,397,000 | 0.31% |
| ADVENT CAPITAL MANAGEMENT /DE/ | 8,379,000 | $11,734,000 | 0.25% |
| PALISADE CAPITAL MANAGEMENT, LP | 5,271,000 | $7,387,000 | 0.19% |
| Calamos Advisors LLC | 23,007,000 | $32,262,000 | 0.19% |
| WESTWOOD HOLDINGS GROUP INC | 10,200,000 | $14,415,000 | 0.17% |